The Jailhouse

[meltdownman]

From Yahoo Message Board:


"While investors wait for the TPIV's submission of the applications for Fast Track & ODD for Ovarian & Triple Negative BC it is interesting to see that the Principal Investigator of the DOD triple negative breast cancer study, Dr. Edith Perez, also become an employee of Genentech. She remains as a Professor at the Mayo Clinic. I think that having her onboard gives TPIV an opportunity to partner with a large company like Genentech potentially or a company of that size. Genentech has so many compounds in development & Dr. Perez on board for the TPIV Ph 2 triple negative breast study w/ the 13.3m grant from the D.O.D. I am just watching developments here & trying to make sense of them. They are all positive in my view with the growth in management and putting solid people in place to help the company grow."

Interesting to see if Dart got her the job with Genentech to keep her from leaving.